Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in inflammatory hand osteoarthritis
ISRCTN46445413Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis and erosive hand osteoarthritis (EHOA) comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoints: AUSCAN pain and hand disability and Radiographic progression by Kallman Score. Started Dec 2011; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
hand osteoarthritiserosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on ISRCTN46445413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46445413.